Edesa Biotech, Inc. (EDSA)

Edesa Biotech Financials Overview

Financials in millions USD. Fiscal year is October - September.

Revenue & Profits

Chart

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Sep 30, 2025	Sep 30, 2024	Sep 30, 2023	Sep 30, 2022	Sep 30, 2021
Operating Income Operating Income Growth	-13.39	-7.91	-7.01	-9.22	-18.37	-23.68
Net Income Net Income Growth	-12.95	-7.19	-6.17	-8.37	-17.55	-13.34
Earnings Per Share EPS Growth	-1.69	-1.27	-1.93	-2.72	-5.46	-7.07
EPS Growth	-	-	-	-	-	-

Cash & Debt

Chart

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Sep 30, 2025	Sep 30, 2024	Sep 30, 2023	Sep 30, 2022	Sep 30, 2021
Cash & Investments Cash & Investments Growth	10.33	10.79	1.04	5.36	7.09	7.84
Total Debt Total Debt Growth	0	0	0.02	0.09	0.02	0.1
Net Cash (Debt) Net Cash Growth	10.33	10.79	1.02	5.27	7.07	7.74
Net Cash Growth	-16.41%	960.70%	-80.68%	-25.52%	-8.63%	9.79%
Net Cash Per Share Net Cash Per Share Growth	1.27	1.90	0.32	1.71	3.07	4.45

Cash Flow & CapEx

Chart

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Sep 30, 2025	Sep 30, 2024	Sep 30, 2023	Sep 30, 2022	Sep 30, 2021
Operating Cash Flow Operating Cash Flow Growth	-9.7	-7.32	-4.89	-6.64	-12.28	-13.66
Capital Expenditures CapEx Growth	-	-	-	-	-0.01	-0.01
Free Cash Flow Free Cash Flow Growth	-9.7	-7.32	-4.89	-6.64	-12.28	-13.67
Free Cash Flow Growth	-	-	-	-	-	-

Valuation

Chart

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug 13, 2026	Sep 30, 2025	Sep 30, 2024	Sep 30, 2023	Sep 30, 2022	Sep 30, 2021
Forward PE	-	0.88	0.88	0.88	56.67	-

Data Source: Fiscal.ai Last updated: Aug 13, 2026

Financial data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 13, 2026

Data Sources Report a data error